V2117
antibody from NSJ Bioreagents
Targeting: MLANA
MART1
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [2]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2117 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- Melan-A Antibody
- Antibody type
- Monoclonal
- Antigen
- Recombinant human Melan-A protein was used as the immunogen for this antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human, Mouse
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- M2-9E3
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the Melan-A antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.
Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.
MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes.
Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation.
A panel immunoblot using co-incubated monoclonal antibodies for identification of melanoma cells.
Hoashi T, Sato S, Yamaguchi Y, Passeron T, Tamaki K, Hearing VJ
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010 May;24(5):1616-29
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010 May;24(5):1616-29
Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.
Hariharan V, Klarquist J, Reust MJ, Koshoffer A, McKee MD, Boissy RE, Le Poole IC
The Journal of investigative dermatology 2010 Jan;130(1):211-20
The Journal of investigative dermatology 2010 Jan;130(1):211-20
MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes.
Hoashi T, Watabe H, Muller J, Yamaguchi Y, Vieira WD, Hearing VJ
The Journal of biological chemistry 2005 Apr 8;280(14):14006-16
The Journal of biological chemistry 2005 Apr 8;280(14):14006-16
Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation.
Trejo O, Reed JA, Prieto VG
Journal of cutaneous pathology 2002 Aug;29(7):397-406
Journal of cutaneous pathology 2002 Aug;29(7):397-406
A panel immunoblot using co-incubated monoclonal antibodies for identification of melanoma cells.
Wang R, Dworak LJ, Lacy MJ
Journal of immunological methods 2001 Mar 1;249(1-2):167-83
Journal of immunological methods 2001 Mar 1;249(1-2):167-83
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin/paraffin human melanoma stained with MART-1 / Melan-A antibody (M2-9E3). Note cytoplasmic staining of cells.
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin/paraffin human melanoma stained with MART-1 / Melan-A antibody (M2-9E3). Note cytoplasmic staining of cells.
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- SDS-PAGE Analysis of Purified, BSA-Free Melan-A Antibody (clone M2-9E3). Confirmation of Integrity and Purity of the Antibody.